1. Academic Validation
  2. Design, synthesis and biological evaluation of novel guanidine-containing matrine derivatives as Topo I/II dual target inhibitors

Design, synthesis and biological evaluation of novel guanidine-containing matrine derivatives as Topo I/II dual target inhibitors

  • Eur J Med Chem. 2026 Sep 5:313:118884. doi: 10.1016/j.ejmech.2026.118884.
Shihao Li 1 Yu Zhu 2 Yonghui Wang 3 Xuan Liu 3 Zheng Xu 3 Qinghai Dong 3 Shuobing Wang 3 Linlin Cui 3 Chunyan Lv 3 Zhihua Xing 3 Yiru Wang 3 Guanghuan Shen 4 Guoyu Li 5
Affiliations

Affiliations

  • 1 College of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China. Electronic address: 15964170810@163.com.
  • 2 College of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China. Electronic address: 13882180549@163.com.
  • 3 College of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China.
  • 4 College of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China. Electronic address: shengh@hrbcu.edu.cn.
  • 5 College of Pharmacy, Harbin University of Commerce, Harbin, 150076, PR China. Electronic address: liguoyu@hrbcu.edu.cn.
Abstract

Topoisomerase inhibitors are a key focus in the development of antitumor agents. In this work, using matrine as a lead compound, a series of novel derivatives were designed and synthesized as potential dual inhibitors of Topoisomerase I and II (Topo I/II). Among these compounds, A6 and A10 exhibited significant cytotoxicity against MCF-7 cells, with IC50 values of 0.6 μM and 0.7 μM, respectively, comparable to those of the positive controls (CPT, VP-16). Given their superior cytotoxicity and dual Topo I/II inhibitory activity, these two compounds were selected for further pharmacological evaluation. Mechanistic investigations demonstrated that A6 and A10 effectively suppressed the proliferation, invasion, and migration of MCF-7 cells in vitro by inducing DNA damage and activating the mitochondrial apoptotic pathway. Collectively, these findings underscore the potential of A6 and A10 as novel dual Topo I/II inhibitors for Cancer therapy.

Keywords

Antitumor activity; Apoptosis; Dual Topo I/II inhibitors; Matrine derivatives.

Figures
Products